Skip to main content
  • News & events
  • Insights
  • Careers
  • Contact
  • Search
Sign in
United States of America
Home
  • About Fujirebio
  • Products & solutions
  • CDMO (OEM)
  • Neuro
  • Home
  • About Fujirebio
  • Products & solutions
  • Neuro
  • HPV
  • CDMO (OEM)
  • Quality
  • Insights
  • Conditions of Sale
  • FAQ
  • Resource center
  • Product Documentation
  • Partner Portal
  • Sign in | register
  • News & events
  • Careers
  • Contact
  • Whistleblower Policy
  • Home
  • News & events

News & events

Upcoming events

May 28, 2026 - May 30, 2026

XVII Congrés Català de Ciències de Laboratori Clínic

Vilafranca del Penedès,
Spain

More info and meet us there

May 29, 2026 - May 29, 2026

Convegno Regionale Parkinson e PARKINSONISMI UP DATE

Ancona,
Italy

More info and meet us there

Jun 1, 2026 - Jun 5, 2026

8th Course Biomarkers for Neurodegenerative Diseases

Barcelona,
Spain

More info and meet us there

See all upcoming events

Latest news

Nov 16, 2011

Innogenetics showcases its LUMIPULSE® G1200 for the first time in Europe at the SIMEL/SIBIOC congress

Innogenetics, an international diagnostics company that develops and markets diagnostic products to improve therapy management and patient health, announced the Italian launch of its LUMIPULSE® G1200, a fully automated chemiluminescent enzyme immunoassay (CLEIA) system, at the 1° Congresso della Medicina di Laboratorio (SIMel/SIBioC) in Parma, Italy on November 16.

Read more

Sep 23, 2010

Fujirebio completed the acquisition of Innogenetics

Fujirebio, a Miraca Holdings group company, has completed the acquisition of all of the issued and outstanding shares of Innogenetics NV.

Read more

Veuillez confirmer que vous êtes un professionnel de la santé

Le contenu de ce site web est en partie réservé aux professionnels de santé qui sont directement impliqués dans la fourniture de services de soins de santé aux patients. Si vous êtes un professionnel de santé et que vous disposez de tous les droits d'accès, veuillez confirmer en cliquant sur le bouton 'oui'.

Choose your country or region

Once you have made this selection we will show you only the content that is relevant for your country. You can change this setting any time by clicking on the flag in the top toolbar of our website and choosing another country.
The content of this website is in part restricted to healthcare professionals who are directly involved in the provision of healthcare services to patients. If you are a health professional and you have full access rights, please check this box and confirm below.
Home
  • Home
  • About Fujirebio
  • Products & solutions
  • Neuro
  • HPV
  • CDMO (OEM)
  • Quality
  • Insights
  • News & events
  • Careers
  • Contact
  • Whistleblower Policy
  • Conditions of Sale
  • FAQ
  • Resource center
  • Product Documentation
  • Partner Portal
  • Sign in | register

Follow us on:

FUJIREBIO is an H.U. Group company.

  • © Fujirebio
  • Website Terms and Conditions
  • Privacy Policy
  • Cookie Policy
  • Trasparenza
site by D'M&S
  • Home
  • About Fujirebio
    • Message from the CEO
    • Global leadership
    • Fujirebio at a glance
    • History
    • Global Office Locations
    • Sustainability and social responsability
  • Products & solutions
  • Neuro
    • Alzheimer's disease testing solutions
    • The Fujirebio Neuro Center of Excellence
    • NExT - the Neuro Expert Toolbox
  • HPV
  • CDMO (OEM)
    • Antibody Identification and Characterization
    • Antibody Supply
    • Contract Manufacturing
    • Product Development
    • Clinical Services
    • Regulatory Services
  • Quality
  • Insights
    • Webinars
  • News & events
  • Careers
  • Contact
  • Whistleblower Policy
  • Conditions of Sale
  • FAQ
  • Resource center
  • Product Documentation
  • Partner Portal
  • Sign in | register
Sign in